Review: taking Lamictal and Remeron together


Summary

Drug interactions are reported among people who take Lamictal and Remeron together. This review analyzes the effectiveness and drug interactions between Lamictal and Remeron. It is created by eHealthMe based on reports of 1,406 people who take the same drugs from FDA and social media, and is updated regularly.

Personalized health information

On eHealthMe you can find out what patients like me (same gender, age) reported their drugs and conditions on FDA and social media since 1977. Our tools are free and anonymous. 86 million people have used us. 300+ peer-reviewed medical journals have referenced our original studies. Start now >>>


Lamictal

Lamictal has active ingredients of lamotrigine. It is often used in bipolar disorder. (latest outcomes from Lamictal 53,475 users)

Remeron

Remeron has active ingredients of mirtazapine. It is often used in depression. (latest outcomes from Remeron 16,341 users)

On Sep, 16, 2016

1,406 people who take Lamictal, Remeron are studied.


Number of reports submitted per year:

Lamictal and Remeron drug interactions.

Drug effectiveness over time:

Lamictal:
  • < 1 month: 0.0% - (0 of 5 people)
  • 1 - 6 months: 15.0% - (2 of 13 people)
  • 6 - 12 months: 40.0% - (4 of 10 people)
  • 1 - 2 years: 43.0% - (7 of 16 people)
  • 2 - 5 years: 55.0% - (5 of 9 people)
  • 5 - 10 years: 37.0% - (3 of 8 people)
  • 10+ years: 0.0% - (0 of 1 people)
  • not specified: 0.0% - (0 of 1 people)
Remeron:
  • < 1 month: 0.0% - (0 of 4 people)
  • 1 - 6 months: 36.0% - (7 of 19 people)
  • 6 - 12 months: 28.0% - (2 of 7 people)
  • 1 - 2 years: 38.0% - (5 of 13 people)
  • 2 - 5 years: 55.0% - (5 of 9 people)
  • 5 - 10 years: 66.0% - (2 of 3 people)
  • 10+ years: 50.0% - (1 of 2 people)
  • not specified: 0.0% - (0 of 0 people)

Drug effectiveness by gender:

Lamictal:
  • female: 38.0% - (14 of 36 people)
  • male: 25.0% - (7 of 27 people)
Remeron:
  • female: 43.0% - (14 of 32 people)
  • male: 32.0% - (8 of 25 people)

Drug effectiveness by age:

Lamictal:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 0.0% - (0 of 1 people)
  • 20-29: 41.0% - (5 of 12 people)
  • 30-39: 42.0% - (8 of 19 people)
  • 40-49: 33.0% - (3 of 9 people)
  • 50-59: 9.0% - (1 of 11 people)
  • 60+: 36.0% - (4 of 11 people)
Remeron:
  • 0-1: 0.0% - (0 of 0 people)
  • 2-9: 0.0% - (0 of 0 people)
  • 10-19: 100.0% - (1 of 1 people)
  • 20-29: 27.0% - (3 of 11 people)
  • 30-39: 43.0% - (7 of 16 people)
  • 40-49: 62.0% - (5 of 8 people)
  • 50-59: 30.0% - (3 of 10 people)
  • 60+: 27.0% - (3 of 11 people)

Most common drug interactions over time *:

< 1 month:
  • rash
  • blood creatine phosphokinase increased
  • stevens-johnson syndrome
  • restless legs syndrome
  • pyrexia
  • drug eruption
  • dehydration
  • depression
  • overdose
  • suicide attempt
1 - 6 months:
  • rash
  • pyrexia
  • chills
  • tremor
  • anxiety
  • dry skin
  • aches and pains in bones
  • bowel movement irregularity
  • dry mouth
  • dry throat
6 - 12 months:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • suicidal ideation
  • abdominal pain lower
  • anxiety, apprehension, feeling uptight, jitters, stress, stress and anxiety, tension
  • arthritis - neck
  • back pain - low
  • blind
  • blurred vision
  • crying
  • depression - chronic
1 - 2 years:
  • agoraphobia
  • anxiety disorder
  • crying - excessive (0-6 months)
  • depressed mood
  • diarrhoea aggravated
  • tooth loss
  • attention deficit/hyperactivity disorder
  • bipolar 1
  • depression
  • diabetes
2 - 5 years:
  • jaundice
  • septic shock
  • body temperature increased
  • leukopenia
  • respiratory failure
  • pneumonia streptococcal
  • blood bilirubin increased
  • nausea
  • suicidal ideation
  • urinary tract infection
5 - 10 years:
  • convulsion
  • pancytopenia
  • general physical health deterioration
  • ankylosing spondylitis
  • bronchitis
  • chronic lymphocytic leukaemia
  • diabetes insipidus
  • diabetes mellitus
  • glucose tolerance impaired
  • lung infection
10+ years:
  • coma
  • rhabdomyolysis
  • confusional state
  • muscle rigidity
  • myoclonus
  • neuroleptic malignant syndrome
  • psychomotor hyperactivity
  • tremor
  • abnormal behaviour
  • anxiety
not specified:
  • depression
  • diabetes mellitus
  • rash
  • weight increased
  • nausea
  • anxiety
  • type 2 diabetes mellitus
  • insomnia
  • suicide attempt
  • convulsion

Most common drug interactions by gender *:

female:
  • depression
  • rash
  • anxiety
  • cardiac arrest
  • diabetes mellitus
  • overdose
  • pyrexia
  • oedema peripheral
  • convulsion
  • weight increased
male:
  • depression
  • suicide attempt
  • nausea
  • rash
  • drug ineffective
  • insomnia
  • weight increased
  • chest pain
  • diabetes mellitus
  • type 2 diabetes mellitus

Most common drug interactions by age *:

0-1:
  • blood cholesterol increased
  • blood triglycerides increased
  • diabetes mellitus
  • drug withdrawal syndrome neonatal
  • hyperlipidaemia
  • neonatal respiratory distress syndrome
  • neuroleptic malignant syndrome
  • ovarian cyst
2-9:
  • aggression
  • blood chloride decreased
  • electroencephalogram abnormal
  • eosinophilia
  • inappropriate antidiuretic hormone secretion
  • leukocytosis
  • mental impairment
  • neutropenia
  • neutrophilia
  • syncope
10-19:
  • exhaustion, fatigue, lethargy, tiredness, weariness
  • agitation
  • rash
  • suicide attempt
  • pyrexia
  • depression
  • disturbance in attention
  • drug ineffective
  • headache
  • somnolence
20-29:
  • pancreatitis acute
  • intentional overdose
  • completed suicide
  • ataxia
  • intentional self-injury
  • metabolic acidosis
  • nystagmus
  • lethargy
  • tachycardia
  • altered state of consciousness
30-39:
  • depression
  • overdose
  • cardiac arrest
  • persecutory delusion
  • seizure
  • paranoia
  • rash
  • nausea
  • weight increased
  • type 2 diabetes mellitus
40-49:
  • convulsion
  • septic shock
  • type 2 diabetes mellitus
  • cardiac arrest
  • depression
  • febrile neutropenia
  • diabetes mellitus
  • oral candidiasis
  • neuropathy peripheral
  • general physical health deterioration
50-59:
  • diabetes mellitus
  • white blood cell count decreased
  • oedema peripheral
  • gastrointestinal carcinoma
  • suicide attempt
  • dizziness
  • weight increased
  • haemorrhage
  • anaemia
  • hypotension
60+:
  • depression
  • suicide attempt
  • stevens-johnson syndrome
  • tremor
  • rash
  • leukopenia
  • nausea
  • oedema peripheral
  • neutropenia
  • dehydration

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Do you take Lamictal and Remeron?

Can you answer these questions?

More questions for: Lamictal, Remeron

You may be interested in these reviews

More reviews for: Lamictal, Remeron

On eHealthMe, Lamictal (lamotrigine) is often used to treat bipolar disorder. Remeron (mirtazapine) is often used to treat depression. Find out below the conditions the drugs are used for and how effective they are.

What is the drug used for and how effecitve is it:


NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.